Melatonin in older adults to lower heart and cancer risks
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at whether melatonin (a hormone-like sleep aid) can reduce the risk of cardiovascular events (like heart attack or stroke) and malignant tumors (cancers) in older adults. You may be considered if you are in the right age range and do not have certain prior conditions or medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 60 to 74 years old
- If you are female, you must be post-menopause
- No past history of cancer (except non-melanoma skin cancer) and no history of heart attack, stroke/TIA, angina, CABG, or stent/angioplasty
- No mental illness and no known allergy to supplements
- No recent participation in another treatment study within the last year
- Not on antidepressant medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether melatonin can help improve heart health in midlife women with high blood pressure. It involves taking a melatonin pill or placebo for several weeks and checking blood pressure and other health markers.
This study tests if taking melatonin and doing a supervised exercise program together can improve health and well-being in women who had breast cancer 5 or more years ago and have gone through menopause. It aims to find a safe, natural way to feel better after treatment.
This trial tests if adding melatonin to standard heart medication helps protect the heart muscle in people with cardiomyopathy. If you are stable on your current heart meds, you may be able to join.
This study tests whether taking 5 mg of melatonin can improve thinking and brain health over time in older adults with early, mild symptoms. You may help researchers learn which brain changes and measures improve with melatonin.
This trial tests whether adding melatonin to standard chemotherapy before surgery can help treat breast cancer. The goal is to see if melatonin improves how well the chemotherapy works.
This trial tests a new inhaled form of melatonin to help adults aged 55 and older with insomnia fall asleep faster. It compares the inhaled melatonin to a placebo to see if it improves sleep and is safe.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.